GlassScriptPhysician profile
Daniel J Mckernan
NPI 1669569091
$12,210.52
in general payments reported to CMS, 2019-2025
18 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $798 · 2021: $69.73 · 2022: $509 · 2023: $1,728 · 2024: $6,191 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,779 · Food and Beverage: $2,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,778.84 |
| Food and Beverage | $2,190.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,127.71 | 2019-2024 | Rosa, Persona |
| Arthrex, INC. | $3,876.50 | 2022-2025 | |
| Cdc Medical LLC | $1,419.00 | 2019 | |
| Miach Orthopaedics, INC. | $188.62 | 2025 | |
| Rock Medical Orthopedics, INC. | $133.21 | 2023 | |
| Depuy Synthes Sales INC. | $119.70 | 2020-2025 | Rigidloop, Twistr, Lupine Orthocord |
| Nexus Medical Technologies LLC | $52.51 | 2025 | |
| Pacira Therapeutics, INC. | $44.27 | 2019-2021 | |
| Stryker Corporation | $41.69 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.15 | 2019 | |
| Ethicon US, LLC | $34.03 | 2025 | Vistaseal |
| Bioventus LLC | $30.82 | 2019-2024 | Gelsyn-3 |
| Heron Therapeutics, INC. | $25.64 | 2023 | Zynrelef |
| Philips North America LLC | $18.39 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.06 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $17.09 | 2023 | Maci |
| Kci USA, INC. | $13.53 | 2021 | |
| Amgen INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mckernan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.